1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. REPLIGEN CORP.
180.71 3.82 (2.16%)
856.4K
XNAS Volume

XNAS 21 Sep, 2026 4:06 PM (EDT)

Watchlist

Portfolio

Alert

Repligen Corp - RGEN - stock price prediction, stock price target, analyst ratings from 23 analysts

Repligen Corp has a share price target of US$ 189, revenue growth forecast of 12.0%, and profit growth estimate of -14.3% for FY26, based on top 23 analyst calls.